Literature DB >> 35023108

Urticaria from the Neurodermatological Perspective: A Temporal Analysis of Urticaria and Cognition.

Tagka A1, George I Lambrou2, Aikaterini Kyritsi3, Styliani A Geronikolou4, Electra Nikolaidou3, Alexandra Katsarou3, Argyro Chatziioannou3, Alexandros Stratigos3, Dimitris Rigopoulos3.   

Abstract

Chronic spontaneous urticaria (CSU, or CU) is a disease that significantly affects the quality of life of patients. The connection between the cognitive state of an individual and dermatological diseases has been previously reported, and it is known, although not thoroughly investigated, that there is a cognitive and quality of life relation to dermal pathologies. Urticaria is a chronic disease that requires a specialized approach to diagnosis and treatment but also a holistic approach with respect to the consideration of both the pathophysiology of the disease and the cognition status of the patient. The present study aims at analyzing CU score and cognitive indexes with respect to time, as a time series and their subsequent interactions. We have attempted to model the investigated time series in order to unravel possible causative relationships between cognitive/quality of life factors and urticaria. One hundred and eleven patients (29 males/82 females) admitted to our department were diagnosed with CU. CU was estimated on UAS7 score basis, which was used in order to define disease severity. Indexes used for assessing the cognitive and quality of life of patients' status included the Urticaria Control Test (UCT) and Dermatology Life Quality Index (DLQI). Significant correlations were found between UAS7 score and the UCT and DLQI scores, respectively. Interestingly, each score time series was modelled by different sets of equations, indicating the unique effect each one has on the disease, as well as that each score probably is manifested by a different pathophysiological mechanism.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Anxiety; Cognition; Quality of Life; Stress; Time series; Urticaria

Mesh:

Year:  2021        PMID: 35023108     DOI: 10.1007/978-3-030-78787-5_26

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  34 in total

1.  Antihistamine-resistant chronic spontaneous urticaria: 1-year data from the AWARE study.

Authors:  Marcus Maurer; Ulrike Raap; Petra Staubach; Grit Richter-Huhn; Andrea Bauer; Eva M Oppel; Uwe Hillen; Daniel Baeumer; Maximilian Reinhardt; Nadine Chapman-Rothe
Journal:  Clin Exp Allergy       Date:  2018-12-07       Impact factor: 5.018

Review 2.  [Skin and stress].

Authors:  S Consoli
Journal:  Pathol Biol (Paris)       Date:  1996-12

3.  The burden of chronic urticaria: French baseline data from the international real-life AWARE study.

Authors:  Gérard Guillet; Pierre-André Bécherel; Pauline Pralong; Marielle Delbarre; Omar Outtas; Laurent Martin; Berengère Pelvet; Hakam Gharbi; Françoise Giordano-Labadie
Journal:  Eur J Dermatol       Date:  2019-02-01       Impact factor: 3.328

Review 4.  Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.

Authors:  A P Kaplan; A M Giménez-Arnau; S S Saini
Journal:  Allergy       Date:  2017-01-04       Impact factor: 13.146

Review 5.  Treating IgE-mediated diseases via targeting IgE-expressing B cells using an anti-CεmX antibody.

Authors:  Sean S Liour; Andrew Tom; Yueh-Hsuan Chan; Tse Wen Chang
Journal:  Pediatr Allergy Immunol       Date:  2016-05-18       Impact factor: 6.377

Review 6.  The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria.

Authors:  Tse Wen Chang; Christina Chen; Chien-Jen Lin; Martin Metz; Martin K Church; Marcus Maurer
Journal:  J Allergy Clin Immunol       Date:  2014-06-17       Impact factor: 10.793

Review 7.  Urticaria: A comprehensive review: Epidemiology, diagnosis, and work-up.

Authors:  Camila Antia; Katherine Baquerizo; Abraham Korman; Jonathan A Bernstein; Ali Alikhan
Journal:  J Am Acad Dermatol       Date:  2018-10       Impact factor: 11.527

8.  Validity, reliability and interpretability of the Thai version of the urticaria control test (UCT).

Authors:  Kanokvalai Kulthanan; Leena Chularojanamontri; Papapit Tuchinda; Chuda Rujitharanawong; Marcus Maurer; Karsten Weller
Journal:  Health Qual Life Outcomes       Date:  2016-04-14       Impact factor: 3.186

9.  Stress, itch and quality of life in chronic urticaria females.

Authors:  Alicja Ograczyk-Piotrowska; Zofia Gerlicz-Kowalczuk; Anna Pietrzak; Anna M Zalewska-Janowska
Journal:  Postepy Dermatol Alergol       Date:  2018-04-24       Impact factor: 1.837

10.  Impact of chronic urticaria on quality of life and work in Japan: Results of a real-world study.

Authors:  Asako Itakura; Yumiko Tani; Naoko Kaneko; Michihiro Hide
Journal:  J Dermatol       Date:  2018-06-13       Impact factor: 4.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.